Product Images Oxaliplatin

This is a clinical study comparing the median survival of patients receiving Oxaliplatin Injection plus 5-FU/LY with those receiving Irinotecan plus 5-FL. The median survival rate is presented graphically in terms of months of survival time. The statistical analysis shows a significant difference between the two groups (p<0.0001) using the log rank test.*

This is a description of a medication with the NDC code 71288-149-95 called Beonty 3. It is an injection containing oxaliplatin (a cytotoxic agent) that is meant for intravenous use only. Each 10ml of the injection contains 50mg of oxaliplatin, with a concentration of 5mg per milliliter. The medication is made in India by Meitheal Pharmaceuticals Inc. and the label includes the code number AP/DRUGS/03/2011.*

This is a product description for a solution called Oxaliplatin used as a cytotoxic agent for Intravenous use only, available in a single-dose vial. It includes information such as dosage and administration, storage requirements, and precautions. The solution is non-pyrogenic, and the container closure does not contain natural rubber latex. The package insert should be consulted for further information.*

This is a product description of Oxaliplatin Injection in a Single-Dose Vial for intravenous use only. The package insert includes dosage and administration instructions, as well as storage guidelines. The vial contains 100 mg Oxaliplatin USP and sterilized water for injection. It is important not to mix or add the solution to chloride/chloride-containing solutions. The NDC numbers and manufacturer are also listed.*